Brookings, SD—RTI, LLC’s Diagnostic Laboratory—which focuses on animal health, food safety, milk and air quality, and seed health testing, in addition to custom-tailored special projects—announces it has upgraded its ISO 17025:2005 accreditation to ISO 17025:2017, the highest recognized quality standard in the world for calibration and testing laboratories. The new ISO 17025:2017 regulations build on the old, incorporating additional stipulations concerned with risk assessment and management, the recognition of threats to impartiality, the inclusion of sampling as a laboratory activity, and the implementation and utilization of decision rules, among others.
RTI’s qualification process wrapped up in September of this year, by means of an independent third-party accreditation body. The internal accreditation team was led by Sonja Van Holland (MT, ASCP), Lab Director; Jaydin Rowbotham, Lab Manager; Alesha Siegel, Quality Assurance Manager; and Julee Driver, Ph.D., as Quality Assurance Consultant. The process was smooth and unproblematic, resulting in no findings.
This accreditation affords clients a justification for the confidence they place in the test data they receive, assuring them that results are precise, accurate, and impartial, and attesting to the robustness of the comprehensive quality management system which functions as RTI’s operational framework.
RTI’s scope of accreditation covers 14 pathogen and spoilage organism detection tests as they relate to food, dairy, and environmental samples. That said, the Diagnostic Laboratory strives to apply consistent ISO 17025-caliber documentation and methodology to all assays, whether or not they are included on the official scope. In the coming months, RTI will explore the development of a roadmap for scope expansion, to include additional assay offerings and recognize them as officially meeting the ISO 17025 standard.
Our organization has been leading the way in the field of animal health and biomedical research since 1994, and offering diagnostic services in the areas of food safety, milk quality, environmental quality, seed health, seed biologics, veterinary microbiology, and customized microbiology projects for a wide variety of agricultural and animal health clients since 2014. With plentiful years of experience and a wealth of history behind us, we look forward to the opportunities of the future as we each strive, individually and cooperatively, to evolve into more efficient, consistent, authentic, and imaginative versions of ourselves as professionals, colleagues, and human beings.
For further information on RTI, LLC and its testing capabilities, don’t hesitate to contact Sonja at firstname.lastname@example.org, or by phone, at 605-696-7300.
RTI is a leading biomedical contract research organization, providing global clients in animal and human health, biopharma, and advanced feed/nutrition industries with premier quality services and product development support. RTI's pre-clinical and clinical research teams routinely conduct both GLP and GCP studies and have expertise in pharmacology, pathology, vaccinology, microbiology, virology, and immunology. RTI's challenge models (and pathogens) are characterized in the literature and well-accepted by regulatory authorities worldwide as the standard by which many vaccines achieve approval and registration. Their Research Laboratory is fully equipped to handle most assays and formats, including ELISA development, and the Diagnostic Laboratory conducts a host of assays under the ISO 17025:2017 standard. Every team member strives to stay at the forefront of animal health care and welfare, new technologies, and governing agency regulatory rules.